Shares of Natco Pharma Limited fall 3.5% after being cited in a U.S. antitrust complaint about a generic cancer medicine. [Representational image only Credit : Unsplash/] Courtesy : TH ; 08/09/2023
Tue. Oct 13th, 2026
Shares of Natco Pharma Limited fall 3.5% after being cited in a U.S. antitrust complaint about a generic cancer medicine. [Representational image only Credit : Unsplash/] Courtesy : TH ; 08/09/2023
